4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001415889-25-006589
Director bought 1,600,000 shares at an average $7.95 ($12,713,126)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TANG KEVIN Director | 2025-02-28 | Purchase | +399,280 | $7.85 | $3,134,348 | 8,828,780 | I |
| TANG KEVIN Director | 2025-03-03 | Purchase | +100,720 | $7.97 | $802,738 | 8,929,500 | I |
| TANG KEVIN Director | 2025-03-03 | Purchase | +351,962 | $8.02 | $2,822,735 | 9,281,462 | I |
| TANG KEVIN Director | 2025-03-04 | Purchase | +148,038 | $8.00 | $1,184,304 | 9,429,500 | I |
| TANG KEVIN Director | 2025-03-04 | Purchase | +500,000 | $7.92 | $3,960,000 | 9,929,500 | I |
| TANG KEVIN Director | 2025-03-04 | Purchase | +100,000 | $8.09 | $809,000 | 10,029,500 | I |
| Open-market purchases · 1,600,000 sh · avg $7.95 · $12,713,126 | |||||||
Loading xslF345X05/form4-03042025_100358.xml…